by Jon Rappoport<\/p>\n
Who\u2019s reserving the prison cells? The answer: no one.<\/p>\n
These Johnson & Johnson execs are free and rich and powerful, although their crimes should have landed them in jail years ago.<\/p>\n
And before I read the riot act, chapter and verse, let\u2019s get something straight. Everybody\u2019s talking about the Deep State? Well, Big Pharma is an essential part of the Deep State.<\/em><\/p>\n These princes are affecting, with toxic substances, the world population every day. All their lobbying efforts, all their behind-the-scenes political control guarantees they can continue to wage what amounts to chemical warfare on the public.<\/p>\n Today\u2019s focus: Johnson & Johnson.<\/strong><\/p>\n SCANDAL ONE: RISPERDAL.<\/strong><\/p>\n March 8, 2017, ibtimes: \u201cMore than 100,000 patients are suing US group Johnson & Johnson, alleging that some of its products have caused them harm. They are claiming an antipsychotic medicine [Risperdal] has resulted in 18,500 men developing a condition known as gynecomastia, or breast swelling after taking the drugs as children.\u201d<\/p>\n \u201cBetween 2016 and 2017, the number of lawsuits disclosed by J&J dramatically increased from 28,300 to 104,700, and along with it, the company\u2019s legal costs, the Financial Times reports.\u201d<\/p>\n \u201cHowever, the troubles of J&J with Risperdal are not new. The company has been accused before of wrongly marketing the drug between 1999 and 2005, promoting it for uses not approved by the US Food and Drug Administration \u2013 including for the treatment of children with attention deficit hyperactivity disorder (ADHD).\u201d<\/p>\n \u201cIn 2013, this led to the company paying more than $2.2bn to settle investigations into its marketing of the drug and other products.\u201d<\/p>\n \u201cThis includes the case of a couple awarded $70m last year by a jury in Philadelphia after their son developed gynecomastia at the age of five, and a man who received $2.5m after growing size 46DD \u2018female breasts\u2019.\u201d<\/p>\n This isn\u2019t the only problem associated with Risperdal. Psychiatrist and author of Toxic Psychiatry, Peter Breggin, writes: \u201cOn May 26, 2000, a jury in the circuit court of Philadelphia awarded $6.7 million to a patient afflicted with tardive dyskinesia caused by the neuroleptic (\u201cantipsychotic\u201d) drug Risperdal (generic name, risperidone). In Liss vs. Doeff, the jury found the psychiatrist negligent in his treatment of Mrs. Elizabeth Liss. The case is among the first involving Risperdal, a relatively new neuroleptic that was put on the market in 1994 and originally promoted as relatively free of the risk of tardive dyskinesia. Peter R. Breggin, M.D., referred the case to the attorneys and acted as a medical consultant throughout the case.\u201d<\/p>\n \u201cMs. Liss developed tardive dyskinesia during a fourteen-month period of exposure to Risperdal as a maintenance treatment for manic-depressive (bipolar) disorder. In previous years, she had several relatively brief exposures to other neuroleptics.\u201d<\/p>\n \u201cTardive dyskinesia is a movement disorder caused by neuroleptic or \u2018antipsychotic\u2019 medications. It can afflict any voluntary muscles of control. It can become severe and disabling, and there are no effective treatments\u2026[NOTE:] Withdrawal from antipsychotic drugs can cause overwhelming emotional and neurological suffering, as well as psychosis in both children and adults, making complete cessation at times very difficult or impossible.\u201d<\/p>\n Is that enough? There\u2019s more.<\/p>\n JOHNSON & JOHNSON SCANDAL TWO: TALC POWDER.<\/strong><\/p>\n Ibtimes, 2017: \u201cOther [Johnson & Johnson] drugs have also been blamed for causing harm to patients. More than 3,000 women have so far sued the company, claiming its talc powder caused them to develop ovarian cancer. They accuse J&J of failing to warn them about talc\u2019s potential to increase the risk of ovarian cancer.\u201d<\/p>\n \u201cAt the beginning of March, a St Louis jury rejected one of such lawsuits against J&J related to its talc-based products. However, other cases had previously been lost by the group. In February 2016, J&J was for instance ordered to pay out $72m to the family of a woman who died from ovarian cancer after using the firm\u2019s products for years.\u201d<\/p>\n JOHNSON & JOHNSON SCANDAL THREE: LEVAQUIN.<\/strong><\/p>\n And then there was this\u2014In 2012, Johnson & Johnson settled lawsuits against them for their antibiotic, Levaquin. FiercePharma writes:<\/p>\n \u201cJohnson & Johnson ($JNJ) appears to be in settlement mode. It has knocked off some more pending litigation, having settled about 25% of the 3,400 lawsuits it faced tied to the dangers of taking antibiotic Levaquin\u2026\u201d<\/p>\n \u201cIn a filing in federal court, the drugmaker said it had agreed to settle, for an undisclosed sum, 845 of the legal actions brought by patients who claimed the drugmaker didn\u2019t do enough to warn about the dangers of antibiotic Levaquin, which has been tied to tendon problems, Bloomberg reports. It said it is in negotiations to settle another 190 of the cases.\u201d<\/p>\n \u201cIn 2008, the FDA required all makers of antibiotics that fell in the same class as Levaquin to add a \u2018black box\u2019 warning to the products that the fluoroquinolones were tied to higher risks of tendon ruptures.\u201d<\/p>\n Medlineplus,gov spells it out further: \u201cTaking levofloxacin [Levaquin] increases the risk that you will develop tendinitis (swelling of a fibrous tissue that connects a bone to a muscle) or have a tendon rupture (tearing of a fibrous tissue that connects a bone to a muscle) during your treatment or for up to several months afterward. These problems may affect tendons in your shoulder, your hand, the back of your ankle, or in other parts of your body. Tendinitis or tendon rupture may happen to people of any age, but the risk is highest in people over 60 years of age\u2026Taking levofloxacin may cause changes in sensation and nerve damage that may not go away even after you stop taking levofloxacin\u2026Taking levofloxacin may affect your brain or nervous system and cause serious side effects. This can occur after the first dose of levofloxacin.\u201d<\/p>\n JOHNSON & JOHNSON SCANDAL FOUR: OVER-THE-COUNTER MEDICINES FOR CHILDREN AND INFANTS.<\/strong><\/p>\n Let\u2019s go even further back in time.<\/p>\n Washington Post, May 2, 2010: \u201cA division of Johnson & Johnson is recalling 43 over-the-counter medicines made for infants and children \u2014 including liquid versions of Tylenol, Motrin, Zyrtec and Benadryl \u2014 after federal regulators identified what they called deficiencies at the company\u2019s manufacturing facility.\u201d<\/p>\n \u201cThe voluntary recall, which was announced late Friday by McNeil Consumer Healthcare [a subsidiary of Johnson & Johnson], affects hundreds of thousands of bottles of medicine in homes and on store shelves throughout the United States and its territories and in nine other countries \u2014 a vast portion of the children\u2019s medicine market.\u201d<\/p>\n \u201cIn a statement, the company said: \u2018Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles.\u2019 It said the problems may affect \u2018purity, potency or quality\u2019.\u201d<\/p>\n \u201cThis is at least the third major recall of Tylenol products by McNeil since 2008.\u201d<\/p>\n \u201cIn January [2010], McNeil recalled 49 types of Tylenol products made for adults and two Tylenol products made for children after consumers complained of a mold-like odor and of temporary and minor nausea, stomach pain, vomiting and diarrhea. The company determined that some of the medicines had been contaminated by trace amounts of a chemical that is sometimes present on shipping and storage material.\u201d<\/p>\n The NY Times, May 1, 2010, reported that Johnson & Johnson indicated the products might be contaminated with \u201ctiny metal specks.\u201d<\/p>\n JOHNSON & JOHNSON SCANDAL FIVE: HIP-REPLACEMENT RECALL.<\/strong><\/p>\n Also, in 2010, Johnson & Johnson instituted a hip-replacement recall. Wikipedia: \u201cOn August 2009, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market\u2026Pathologically, the failing prosthesis had several effects. Metal debris from wear of the implant led to a reaction that destroyed the soft tissues surrounding the joint, leaving some patients with long term disability. Ions of cobalt and chromium\u2014the metals from which the implant was made\u2014were also released into the blood and cerebral spinal fluid in some patients.\u201d<\/p>\n \u201cIn March 2013, a jury in Los Angeles ordered Johnson & Johnson to pay more than $8.3 million in damages to a Montana man in the first of more than 10,000 lawsuits pending against the company in connection with the now-recalled DePuy hip.\u201d<\/p>\n \u201cSome lawyers and industry analysts have estimated that the suits ultimately will cost Johnson & Johnson billions of dollars to resolve.\u201d<\/p>\n JOHNSON & JOHNSON SCANDAL SIX: 2010 SHAREHOLDERS LAWSUIT AGAINST THE COMPANY.<\/strong><\/p>\n Wikipedia: \u201cIn 2010 a group of shareholders sued the board for allegedly failing to take action to prevent serious failings and illegalities since the 1990s, including manufacturing problems, bribing officials, covering up adverse effects and misleading marketing for unapproved uses. The judge initially dismissed the case in September 2011, but allowed the plaintiffs opportunity to refile at a later time. In 2012 Johnson and Johnson proposed a settlement with the shareholders, whereby the company would institute new oversight, quality and compliance procedures binding for five years.\u201d<\/p>\n SCANDAL SEVEN: THE JOHNSON & JOHNSON\/BIEDERMAN AFFAIR.<\/strong><\/p>\n From psychcentralcom: \u201cThe trickle of incriminating evidence against Dr. Joseph Biederman, a Harvard world-renowned child psychiatrist known for his advocacy of \u2018pediatric bipolar disorder,\u2019 has turned into a torrent \u2014 of emails and internal documents.\u201d<\/p>\n \u201cThe New York Times reports, based upon the release of court documents containing internal documents and emails, that Dr. Biederman was allegedly paid by Johnson & Johnson (J&J) for his promotion of pediatric bipolar disorder and research into showing the efficacy of a [highly toxic and dangerous] drug used to treat it, Risperdal.\u201d<\/p>\n \u201cThe Philadelphia Inquirer\u2019s take: \u2018Johnson & Johnson gave hundreds of thousands of dollars to a research center run by an influential child psychiatrist [Biederman] explicitly to generate data to help expand sales of the company\u2019s antipsychotic drug Risperdal in children, according to court documents.\u201d<\/p>\n Essentially, Biederman was the prime figure who convinced the psychiatric community that childhood bipolar disease was a real condition\u2014and then took money to promote drug treatment for it, including Risperdal, a Johnson & Johnson drug. Johnson & Johnson paid Biederman to run a research center that would help the company market and sell the drug.<\/p>\n Note: there is no defining physical test of any kind that diagnoses pediatric bipolar disease. No blood test, urine test, brain scan, genetic assay.<\/p>\n JOHNSON & JOHNSON SCANDAL EIGHT: NOBODY GOES TO PRISON.<\/strong><\/p>\n The assessed fines for scandals and crimes haven\u2019t put the company out of business. Not by a long shot.<\/p>\n These Johnson & Johnson executives roam free.<\/p>\n What would they have to do to find themselves behind bars for 20 years?<\/p>\n Carpet-bomb the US?<\/p>\n